Literature DB >> 15642225

Astragalus membranaceus reduces free radical-mediated injury to renal tubules in rabbits receiving high-energy shock waves.

Bin-wu Sheng1, Xing-fa Chen, Jun Zhao, Da-lin He, Xun-yi Nan.   

Abstract

BACKGROUND: Recent studies have revealed the important role of free radicals in renal damage induced by high-energy shock waves (HESW). This study aimed at investigating the effects of Astragalus membranaceus, a traditional Chinese medicinal herb, on free radical-mediated HESW-induced damage to renal tubules in a live rabbit model.
METHODS: Forty-five healthy male New Zealand white rabbits were randomly divided into three groups: control group (n = 15), sham group (n = 15), and herb-treated group (n = 15). Three days prior to HESW application, the controls received verapamil (0.4 mg/kg), the shams received physiological saline (20 ml), and the herb-treated animals received Astragalus membranaceus (2.4 g/kg) intravenously. HESW (1500 shocks, 18 kV) was applied to the right kidneys of all anesthetized rabbits. We measured superoxide dismutase (SOD) and malondialdehyde (MDA) levels before and after shock treatment in blood and kidney homogenates. Histopathological changes were also observed.
RESULTS: MDA levels increased and SOD activity decreased significantly in the sham group (P < 0.05 for both) after shock treatment. MDA levels showed a much less increase in the controls (P < 0.05) and did not increase to statistically significant levels in the group receiving Astragalus membranaceus (P > 0.05). SOD values were significantly higher in the controls than in the shams (P < 0.05). By contrast, SOD levels recovered rapidly in the rabbits receiving Astragalus membranaceus, reaching a nadir within 24 hours, and returning to baseline more quickly than in control and sham rabbits (P < 0.05). Histopathological examinations showed that renal tubular damage in the controls was less severe than in the shams, while damage in the Astragalus membranaceus group was even more mild, with rapid recovery in comparison with the controls.
CONCLUSION: This study provides preliminary evidence indicating that Astragalus membranaceus has strong protective effects on free radical-mediated renal tubular damage induced by HESW and that these effects are superior to the effects of verapamil.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15642225

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  6 in total

1.  A novel antioxidant agent, astragalosides, prevents shock wave-induced renal oxidative injury in rabbits.

Authors:  Xiang Li; Dalin He; Linlin Zhang; Xinfa Cheng; Binwu Sheng; Yong Luo
Journal:  Urol Res       Date:  2006-06-17

2.  The protective effects of the traditional Chinese herbs against renal damage induced by extracorporeal shock wave lithotripsy: a clinical study.

Authors:  Binwu Sheng; Dalin He; Jun Zhao; Xingfa Chen; Xunyi Nan
Journal:  Urol Res       Date:  2010-07-06

3.  Localization of renal oxidative stress and inflammatory response after lithotripsy.

Authors:  Daniel L Clark; Bret A Connors; Andrew P Evan; Lynn R Willis; Rajash K Handa; Sujuan Gao
Journal:  BJU Int       Date:  2009-01-20       Impact factor: 5.588

Review 4.  Efficacy of Chinese Herbal Medicine as an Adjunctive Therapy on in-Hospital Mortality in Patients with Acute Kidney Injury: A Systematic Review and Meta-Analysis.

Authors:  Tuo Chen; Libin Zhan; Zhiwei Fan; Lizhi Bai; Yi Song; Xiaoguang Lu
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-03       Impact factor: 2.629

5.  Astragalus membranaceus Extract Prevents Calcium Oxalate Crystallization and Extends Lifespan in a Drosophila Urolithiasis Model.

Authors:  Szu-Ju Chen; Sunderiya Dalanbaatar; Huey-Yi Chen; Shih-Jing Wang; Wei-Yong Lin; Po-Len Liu; Ming-Yen Tsai; Der-Cherng Chen; Yung-Hsiang Chen; Wen-Chi Chen
Journal:  Life (Basel)       Date:  2022-08-16

6.  A network pharmacology approach to understanding the mechanisms of action of traditional medicine: Bushenhuoxue formula for treatment of chronic kidney disease.

Authors:  Shao-hua Shi; Yue-piao Cai; Xiao-jun Cai; Xiao-yong Zheng; Dong-sheng Cao; Fa-qing Ye; Zheng Xiang
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.